$ISIS Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in IONIS PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in IONIS PHARMACEUTICALS INC. Get notifications about new insider transactions in IONIS PHARMACEUTICALS INC for free.
Page: < prev 1 2 3 4 5 6 7 ... 28 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 20 2019 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | SVP, Finance & CFO | Option Exercise | M | 10.82 | 7,196 | 77,861 | 0 | |
| Dec 20 2019 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | SVP, Finance & CFO | Payment of Exercise | F | 61.52 | 2,014 | 123,901 | 24,460 | 26.5 K to 24.5 K (-7.61 %) |
| Dec 20 2019 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | SVP, Finance & CFO | Buy | M | 10.82 | 3,438 | 37,199 | 26,474 | 23 K to 26.5 K (+14.92 %) |
| Dec 20 2019 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | SVP, Finance & CFO | Payment of Exercise | F | 61.52 | 4,215 | 259,307 | 23,036 | 27.3 K to 23 K (-15.47 %) |
| Dec 20 2019 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | SVP, Finance & CFO | Buy | M | 10.82 | 7,196 | 77,861 | 27,251 | 20.1 K to 27.3 K (+35.88 %) |
| Dec 19 2019 | ISIS | IONIS PHARMACEUTIC ... | IONIS PHARMACEUTICALS INC | 10% Owner | Buy | J | 0.00 | 6,873,344 | 0 | 77,094,682 | 70.2 M to 77.1 M (+9.79 %) |
| Dec 18 2019 | ISIS | IONIS PHARMACEUTIC ... | KLEIN JOSEPH III | Director | Option Exercise | M | 35.53 | 1,000 | 35,530 | 1,000 | |
| Dec 18 2019 | ISIS | IONIS PHARMACEUTIC ... | KLEIN JOSEPH III | Director | Sell | S | 65.45 | 1,000 | 65,447 | 12,683 | 13.7 K to 12.7 K (-7.31 %) |
| Dec 18 2019 | ISIS | IONIS PHARMACEUTIC ... | KLEIN JOSEPH III | Director | Buy | M | 35.53 | 1,000 | 35,530 | 13,683 | 12.7 K to 13.7 K (+7.88 %) |
| Dec 10 2019 | ISIS | IONIS PHARMACEUTIC ... | KLEIN JOSEPH III | Director | Option Exercise | M | 35.53 | 1,000 | 35,530 | 2,000 | |
| Dec 10 2019 | ISIS | IONIS PHARMACEUTIC ... | KLEIN JOSEPH III | Director | Sell | S | 63.74 | 1,000 | 63,745 | 12,683 | 13.7 K to 12.7 K (-7.31 %) |
| Dec 10 2019 | ISIS | IONIS PHARMACEUTIC ... | KLEIN JOSEPH III | Director | Buy | M | 35.53 | 1,000 | 35,530 | 13,683 | 12.7 K to 13.7 K (+7.88 %) |
| Dec 05 2019 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | SVP, Finance & CFO | Option Exercise | M | 10.82 | 4,062 | 43,951 | 3,438 | |
| Dec 05 2019 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | SVP, Finance & CFO | Option Exercise | M | 10.82 | 504 | 5,453 | 7,196 | |
| Dec 05 2019 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | SVP, Finance & CFO | Sell | S | 65.00 | 4,062 | 264,030 | 20,055 | 24.1 K to 20.1 K (-16.84 %) |
| Dec 05 2019 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | SVP, Finance & CFO | Buy | M | 10.82 | 4,062 | 43,951 | 24,117 | 20.1 K to 24.1 K (+20.25 %) |
| Dec 05 2019 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | SVP, Finance & CFO | Sell | S | 65.00 | 504 | 32,760 | 20,055 | 20.6 K to 20.1 K (-2.45 %) |
| Dec 05 2019 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | SVP, Finance & CFO | Buy | M | 10.82 | 504 | 5,453 | 20,559 | 20.1 K to 20.6 K (+2.51 %) |
| Dec 05 2019 | ISIS | IONIS PHARMACEUTIC ... | Geary Richard S | SVP, Development | Option Exercise | M | 14.69 | 10,000 | 146,900 | 0 | |
| Dec 05 2019 | ISIS | IONIS PHARMACEUTIC ... | Geary Richard S | SVP, Development | Sell | S | 65.00 | 10,000 | 650,000 | 21,583 | 31.6 K to 21.6 K (-31.66 %) |
| Dec 05 2019 | ISIS | IONIS PHARMACEUTIC ... | Geary Richard S | SVP, Development | Buy | M | 14.69 | 10,000 | 146,900 | 31,583 | 21.6 K to 31.6 K (+46.33 %) |
| Dec 04 2019 | ISIS | IONIS PHARMACEUTIC ... | KLEIN JOSEPH III | Director | Option Exercise | M | 35.53 | 1,000 | 35,530 | 3,000 | |
| Dec 04 2019 | ISIS | IONIS PHARMACEUTIC ... | KLEIN JOSEPH III | Director | Sell | S | 64.08 | 1,000 | 64,083 | 12,683 | 13.7 K to 12.7 K (-7.31 %) |
| Dec 04 2019 | ISIS | IONIS PHARMACEUTIC ... | KLEIN JOSEPH III | Director | Buy | M | 35.53 | 1,000 | 35,530 | 13,683 | 12.7 K to 13.7 K (+7.88 %) |
| Dec 04 2019 | ISIS | IONIS PHARMACEUTIC ... | Geary Richard S | SVP, Development | Option Exercise | M | 14.69 | 5,000 | 73,450 | 10,000 | |
| Dec 04 2019 | ISIS | IONIS PHARMACEUTIC ... | Geary Richard S | SVP, Development | Sell | S | 65.06 | 5,000 | 325,287 | 21,583 | 26.6 K to 21.6 K (-18.81 %) |
| Dec 04 2019 | ISIS | IONIS PHARMACEUTIC ... | Geary Richard S | SVP, Development | Buy | M | 14.69 | 5,000 | 73,450 | 26,583 | 21.6 K to 26.6 K (+23.17 %) |
| Nov 26 2019 | ISIS | IONIS PHARMACEUTIC ... | KLEIN JOSEPH III | Director | Sell | S | 62.90 | 812 | 51,075 | 12,683 | 13.5 K to 12.7 K (-6.02 %) |
| Nov 26 2019 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | SVP, Finance & CFO | Option Exercise | M | 10.82 | 4,000 | 43,280 | 7,700 | |
| Nov 26 2019 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | SVP, Finance & CFO | Sell | S | 62.50 | 4,000 | 250,000 | 20,055 | 24.1 K to 20.1 K (-16.63 %) |
| Nov 26 2019 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | SVP, Finance & CFO | Buy | M | 10.82 | 4,000 | 43,280 | 24,055 | 20.1 K to 24.1 K (+19.95 %) |
| Nov 21 2019 | ISIS | IONIS PHARMACEUTIC ... | KLEIN JOSEPH III | Director | Sell | S | 60.00 | 2,000 | 120,000 | 13,495 | 15.5 K to 13.5 K (-12.91 %) |
| Nov 21 2019 | ISIS | IONIS PHARMACEUTIC ... | Monia Brett P | COO & SVP, Translat ... | Sell | S | 60.01 | 5,776 | 346,618 | 16,458 | 22.2 K to 16.5 K (-25.98 %) |
| Nov 21 2019 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | SVP, Finance & CFO | Option Exercise | M | 10.82 | 4,000 | 43,280 | 11,700 | |
| Nov 21 2019 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | SVP, Finance & CFO | Sell | S | 58.80 | 4,000 | 235,200 | 20,055 | 24.1 K to 20.1 K (-16.63 %) |
| Nov 21 2019 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | SVP, Finance & CFO | Buy | M | 10.82 | 4,000 | 43,280 | 24,055 | 20.1 K to 24.1 K (+19.95 %) |
| Oct 17 2019 | ISIS | IONIS PHARMACEUTIC ... | Hayden Michael R | Director | Option Exercise | M | 0.00 | 1,778 | 0 | 5,332 | |
| Oct 17 2019 | ISIS | IONIS PHARMACEUTIC ... | Hayden Michael R | Director | Buy | M | 0.00 | 1,778 | 0 | 1,778 | 0 to 1.8 K |
| Oct 17 2019 | ISIS | IONIS PHARMACEUTIC ... | Reikes Peter N | Director | Option Exercise | M | 0.00 | 1,778 | 0 | 5,332 | |
| Oct 17 2019 | ISIS | IONIS PHARMACEUTIC ... | Reikes Peter N | Director | Buy | M | 0.00 | 1,778 | 0 | 1,778 | 0 to 1.8 K |
| Aug 22 2019 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 39.87 | 10,000 | 398,700 | 27,180 | |
| Aug 22 2019 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 39.87 | 2,000 | 79,740 | 500 | |
| Aug 22 2019 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 39.87 | 10,000 | 398,700 | 37,180 | |
| Aug 22 2019 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 72.15 | 10,000 | 721,500 | 69,634 | 79.6 K to 69.6 K (-12.56 %) |
| Aug 22 2019 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 39.87 | 10,000 | 398,700 | 79,634 | 69.6 K to 79.6 K (+14.36 %) |
| Aug 22 2019 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 71.00 | 2,000 | 142,000 | 5,532 | 7.5 K to 5.5 K (-26.55 %) |
| Aug 22 2019 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 39.87 | 2,000 | 79,740 | 7,532 | 5.5 K to 7.5 K (+36.15 %) |
| Aug 22 2019 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 71.00 | 10,000 | 710,000 | 69,634 | 79.6 K to 69.6 K (-12.56 %) |
| Aug 22 2019 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 39.87 | 10,000 | 398,700 | 79,634 | 69.6 K to 79.6 K (+14.36 %) |
| Jul 22 2019 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman & CEO | Option Exercise | M | 39.87 | 10,000 | 398,700 | 47,180 | |
| Jul 22 2019 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman & CEO | Sell | S | 70.25 | 10,000 | 702,506 | 69,634 | 79.6 K to 69.6 K (-12.56 %) |
| Jul 22 2019 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman & CEO | Buy | M | 39.87 | 10,000 | 398,700 | 79,634 | 69.6 K to 79.6 K (+14.36 %) |
| Jul 17 2019 | ISIS | IONIS PHARMACEUTIC ... | McDevitt Damien | Chief Business Offi ... | Option Exercise | M | 0.00 | 3,542 | 0 | 10,625 | |
| Jul 17 2019 | ISIS | IONIS PHARMACEUTIC ... | McDevitt Damien | Chief Business Offi ... | Payment of Exercise | F | 67.86 | 1,225 | 83,129 | 2,573 | 3.8 K to 2.6 K (-32.25 %) |
| Jul 17 2019 | ISIS | IONIS PHARMACEUTIC ... | McDevitt Damien | Chief Business Offi ... | Buy | M | 0.00 | 3,542 | 0 | 3,798 | 256 to 3.8 K (+1,383.59 %) |
| Jul 03 2019 | ISIS | IONIS PHARMACEUTIC ... | Hayden Michael R | Director | Option Exercise | A | 64.80 | 16,000 | 1,036,800 | 16,000 | |
| Jul 03 2019 | ISIS | IONIS PHARMACEUTIC ... | Hayden Michael R | Director | Option Exercise | A | 0.00 | 7,110 | 0 | 7,110 | |
| Jul 03 2019 | ISIS | IONIS PHARMACEUTIC ... | HERMAN JOAN E | Director | Option Exercise | A | 64.80 | 16,000 | 1,036,800 | 16,000 | |
| Jul 03 2019 | ISIS | IONIS PHARMACEUTIC ... | HERMAN JOAN E | Director | Option Exercise | A | 0.00 | 7,110 | 0 | 7,110 | |
| Jul 03 2019 | ISIS | IONIS PHARMACEUTIC ... | Reikes Peter N | Director | Option Exercise | A | 64.80 | 16,000 | 1,036,800 | 16,000 | |
| Jul 03 2019 | ISIS | IONIS PHARMACEUTIC ... | Reikes Peter N | Director | Option Exercise | A | 0.00 | 7,110 | 0 | 7,110 | |
| Jul 03 2019 | ISIS | IONIS PHARMACEUTIC ... | PARSHALL B LYNNE | Director | Option Exercise | A | 64.80 | 16,000 | 1,036,800 | 16,000 | |
| Jul 03 2019 | ISIS | IONIS PHARMACEUTIC ... | PARSHALL B LYNNE | Director | Option Exercise | A | 0.00 | 7,110 | 0 | 7,110 | |
| Jul 03 2019 | ISIS | IONIS PHARMACEUTIC ... | PARSHALL B LYNNE | Director | Option Exercise | M | 0.00 | 889 | 0 | 2,666 | |
| Jul 03 2019 | ISIS | IONIS PHARMACEUTIC ... | PARSHALL B LYNNE | Director | Buy | M | 0.00 | 889 | 0 | 53,566 | 52.7 K to 53.6 K (+1.69 %) |
| Jul 03 2019 | ISIS | IONIS PHARMACEUTIC ... | KLEIN JOSEPH III | Director | Option Exercise | A | 64.80 | 16,000 | 1,036,800 | 16,000 | |
| Jul 03 2019 | ISIS | IONIS PHARMACEUTIC ... | KLEIN JOSEPH III | Director | Option Exercise | A | 0.00 | 7,110 | 0 | 7,110 | |
| Jul 03 2019 | ISIS | IONIS PHARMACEUTIC ... | KLEIN JOSEPH III | Director | Option Exercise | M | 0.00 | 667 | 0 | 1,333 | |
| Jul 03 2019 | ISIS | IONIS PHARMACEUTIC ... | KLEIN JOSEPH III | Director | Option Exercise | M | 0.00 | 889 | 0 | 2,666 | |
| Jul 03 2019 | ISIS | IONIS PHARMACEUTIC ... | KLEIN JOSEPH III | Director | Option Exercise | M | 0.00 | 667 | 0 | 666 | |
| Jul 03 2019 | ISIS | IONIS PHARMACEUTIC ... | KLEIN JOSEPH III | Director | Option Exercise | M | 0.00 | 666 | 0 | 0 | |
| Jul 03 2019 | ISIS | IONIS PHARMACEUTIC ... | KLEIN JOSEPH III | Director | Buy | M | 0.00 | 667 | 0 | 15,495 | 14.8 K to 15.5 K (+4.50 %) |
| Jul 03 2019 | ISIS | IONIS PHARMACEUTIC ... | KLEIN JOSEPH III | Director | Buy | M | 0.00 | 889 | 0 | 14,828 | 13.9 K to 14.8 K (+6.38 %) |
| Jul 03 2019 | ISIS | IONIS PHARMACEUTIC ... | KLEIN JOSEPH III | Director | Buy | M | 0.00 | 667 | 0 | 13,939 | 13.3 K to 13.9 K (+5.03 %) |
| Jul 03 2019 | ISIS | IONIS PHARMACEUTIC ... | KLEIN JOSEPH III | Director | Buy | M | 0.00 | 666 | 0 | 13,272 | 12.6 K to 13.3 K (+5.28 %) |
| Jul 03 2019 | ISIS | IONIS PHARMACEUTIC ... | MUTO FREDERICK T | Director | Option Exercise | A | 64.80 | 16,000 | 1,036,800 | 16,000 | |
| Jul 03 2019 | ISIS | IONIS PHARMACEUTIC ... | MUTO FREDERICK T | Director | Option Exercise | A | 0.00 | 7,110 | 0 | 7,110 | |
| Jul 03 2019 | ISIS | IONIS PHARMACEUTIC ... | MUTO FREDERICK T | Director | Option Exercise | M | 0.00 | 667 | 0 | 1,333 | |
| Jul 03 2019 | ISIS | IONIS PHARMACEUTIC ... | MUTO FREDERICK T | Director | Option Exercise | M | 0.00 | 889 | 0 | 2,666 | |
| Jul 03 2019 | ISIS | IONIS PHARMACEUTIC ... | MUTO FREDERICK T | Director | Option Exercise | M | 0.00 | 667 | 0 | 666 | |
| Jul 03 2019 | ISIS | IONIS PHARMACEUTIC ... | MUTO FREDERICK T | Director | Option Exercise | M | 0.00 | 666 | 0 | 0 | |
| Jul 03 2019 | ISIS | IONIS PHARMACEUTIC ... | MUTO FREDERICK T | Director | Buy | M | 0.00 | 667 | 0 | 12,683 | 12 K to 12.7 K (+5.55 %) |
| Jul 03 2019 | ISIS | IONIS PHARMACEUTIC ... | MUTO FREDERICK T | Director | Buy | M | 0.00 | 889 | 0 | 12,016 | 11.1 K to 12 K (+7.99 %) |
| Jul 03 2019 | ISIS | IONIS PHARMACEUTIC ... | MUTO FREDERICK T | Director | Buy | M | 0.00 | 667 | 0 | 11,127 | 10.5 K to 11.1 K (+6.38 %) |
| Jul 03 2019 | ISIS | IONIS PHARMACEUTIC ... | MUTO FREDERICK T | Director | Buy | M | 0.00 | 666 | 0 | 10,460 | 9.8 K to 10.5 K (+6.80 %) |
| Jul 03 2019 | ISIS | IONIS PHARMACEUTIC ... | LOSCALZO JOSEPH | Director | Option Exercise | A | 64.80 | 16,000 | 1,036,800 | 16,000 | |
| Jul 03 2019 | ISIS | IONIS PHARMACEUTIC ... | LOSCALZO JOSEPH | Director | Option Exercise | A | 0.00 | 7,110 | 0 | 7,110 | |
| Jul 03 2019 | ISIS | IONIS PHARMACEUTIC ... | LOSCALZO JOSEPH | Director | Option Exercise | M | 0.00 | 667 | 0 | 1,333 | |
| Jul 03 2019 | ISIS | IONIS PHARMACEUTIC ... | LOSCALZO JOSEPH | Director | Option Exercise | M | 0.00 | 889 | 0 | 2,666 | |
| Jul 03 2019 | ISIS | IONIS PHARMACEUTIC ... | LOSCALZO JOSEPH | Director | Option Exercise | M | 0.00 | 667 | 0 | 666 | |
| Jul 03 2019 | ISIS | IONIS PHARMACEUTIC ... | LOSCALZO JOSEPH | Director | Option Exercise | M | 0.00 | 666 | 0 | 0 | |
| Jul 03 2019 | ISIS | IONIS PHARMACEUTIC ... | LOSCALZO JOSEPH | Director | Buy | M | 0.00 | 667 | 0 | 13,308 | 12.6 K to 13.3 K (+5.28 %) |
| Jul 03 2019 | ISIS | IONIS PHARMACEUTIC ... | LOSCALZO JOSEPH | Director | Buy | M | 0.00 | 889 | 0 | 12,641 | 11.8 K to 12.6 K (+7.56 %) |
| Jul 03 2019 | ISIS | IONIS PHARMACEUTIC ... | LOSCALZO JOSEPH | Director | Buy | M | 0.00 | 667 | 0 | 11,752 | 11.1 K to 11.8 K (+6.02 %) |
| Jul 03 2019 | ISIS | IONIS PHARMACEUTIC ... | LOSCALZO JOSEPH | Director | Buy | M | 0.00 | 666 | 0 | 11,085 | 10.4 K to 11.1 K (+6.39 %) |
| Jul 03 2019 | ISIS | IONIS PHARMACEUTIC ... | WENDER JOSEPH H | Director | Option Exercise | A | 64.80 | 16,000 | 1,036,800 | 16,000 | |
| Jul 03 2019 | ISIS | IONIS PHARMACEUTIC ... | WENDER JOSEPH H | Director | Option Exercise | A | 0.00 | 7,110 | 0 | 7,110 | |
| Jul 03 2019 | ISIS | IONIS PHARMACEUTIC ... | WENDER JOSEPH H | Director | Option Exercise | M | 0.00 | 667 | 0 | 1,333 | |
| Jul 03 2019 | ISIS | IONIS PHARMACEUTIC ... | WENDER JOSEPH H | Director | Option Exercise | M | 0.00 | 889 | 0 | 2,666 | |
| Jul 03 2019 | ISIS | IONIS PHARMACEUTIC ... | WENDER JOSEPH H | Director | Option Exercise | M | 0.00 | 667 | 0 | 666 | |
| Jul 03 2019 | ISIS | IONIS PHARMACEUTIC ... | WENDER JOSEPH H | Director | Option Exercise | M | 0.00 | 666 | 0 | 0 | |
| Jul 03 2019 | ISIS | IONIS PHARMACEUTIC ... | WENDER JOSEPH H | Director | Buy | M | 0.00 | 667 | 0 | 61,805 | 61.1 K to 61.8 K (+1.09 %) |
| Jul 03 2019 | ISIS | IONIS PHARMACEUTIC ... | WENDER JOSEPH H | Director | Buy | M | 0.00 | 889 | 0 | 61,138 | 60.2 K to 61.1 K (+1.48 %) |
| Jul 03 2019 | ISIS | IONIS PHARMACEUTIC ... | WENDER JOSEPH H | Director | Buy | M | 0.00 | 667 | 0 | 60,249 | 59.6 K to 60.2 K (+1.12 %) |
| Jul 03 2019 | ISIS | IONIS PHARMACEUTIC ... | WENDER JOSEPH H | Director | Buy | M | 0.00 | 666 | 0 | 59,582 | 58.9 K to 59.6 K (+1.13 %) |
| Jul 02 2019 | ISIS | IONIS PHARMACEUTIC ... | Monia Brett P | Chief Operating Off ... | Sell | S | 66.40 | 210 | 13,944 | 22,234 | 22.4 K to 22.2 K (-0.94 %) |
| Jul 02 2019 | ISIS | IONIS PHARMACEUTIC ... | Monia Brett P | Chief Operating Off ... | Buy | J | 45.70 | 173 | 7,907 | 22,444 | 22.3 K to 22.4 K (+0.78 %) |
| Jul 02 2019 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | SVP Finance & CFO | Buy | J | 45.70 | 105 | 4,799 | 20,055 | 20 K to 20.1 K (+0.53 %) |
| Jul 02 2019 | ISIS | IONIS PHARMACEUTIC ... | Geary Richard S | SVP, Development | Buy | J | 45.70 | 141 | 6,444 | 21,583 | 21.4 K to 21.6 K (+0.66 %) |
| Jul 02 2019 | ISIS | IONIS PHARMACEUTIC ... | BENNETT C FRANK | SVP, Antisense Rese ... | Buy | J | 45.70 | 118 | 5,393 | 24,646 | 24.5 K to 24.6 K (+0.48 %) |
| Jul 02 2019 | ISIS | IONIS PHARMACEUTIC ... | McDevitt Damien | Chief Business Offi ... | Buy | J | 45.70 | 256 | 11,700 | 256 | 0 to 256 |
| Jul 02 2019 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP Legal & General ... | Buy | J | 45.70 | 161 | 7,358 | 16,834 | 16.7 K to 16.8 K (+0.97 %) |
| Jun 26 2019 | ISIS | IONIS PHARMACEUTIC ... | BERTHELSEN SPENCER R | Director | Option Exercise | M | 16.32 | 15,000 | 244,800 | 0 | |
| Jun 26 2019 | ISIS | IONIS PHARMACEUTIC ... | BERTHELSEN SPENCER R | Director | Sell | S | 63.84 | 9,690 | 618,639 | 94,094 | 103.8 K to 94.1 K (-9.34 %) |
| Jun 26 2019 | ISIS | IONIS PHARMACEUTIC ... | BERTHELSEN SPENCER R | Director | Buy | M | 16.32 | 9,690 | 158,141 | 103,784 | 94.1 K to 103.8 K (+10.30 %) |
| Jun 26 2019 | ISIS | IONIS PHARMACEUTIC ... | BERTHELSEN SPENCER R | Director | Sell | S | 63.37 | 5,310 | 336,474 | 94,094 | 99.4 K to 94.1 K (-5.34 %) |
| Jun 26 2019 | ISIS | IONIS PHARMACEUTIC ... | BERTHELSEN SPENCER R | Director | Buy | M | 16.32 | 5,310 | 86,659 | 99,404 | 94.1 K to 99.4 K (+5.64 %) |
| Jun 12 2019 | ISIS | IONIS PHARMACEUTIC ... | HERMAN JOAN E | Director | Option Exercise | A | 0.00 | 14,221 | 0 | 14,221 | |
| Jun 12 2019 | ISIS | IONIS PHARMACEUTIC ... | HERMAN JOAN E | Director | Option Exercise | A | 63.90 | 32,000 | 2,044,800 | 32,000 | |
| Jun 06 2019 | ISIS | IONIS PHARMACEUTIC ... | MUTO FREDERICK T | Director | Option Exercise | M | 16.32 | 15,000 | 244,800 | 0 | |
| Jun 06 2019 | ISIS | IONIS PHARMACEUTIC ... | MUTO FREDERICK T | Director | Sell | S | 65.29 | 15,000 | 979,350 | 9,794 | 24.8 K to 9.8 K (-60.50 %) |
| Jun 06 2019 | ISIS | IONIS PHARMACEUTIC ... | MUTO FREDERICK T | Director | Buy | M | 16.32 | 15,000 | 244,800 | 24,794 | 9.8 K to 24.8 K (+153.15 %) |
| May 08 2019 | ISIS | IONIS PHARMACEUTIC ... | MUTO FREDERICK T | Director | Option Exercise | M | 24.42 | 8,000 | 195,360 | 0 | |
| May 08 2019 | ISIS | IONIS PHARMACEUTIC ... | MUTO FREDERICK T | Director | Sell | S | 72.75 | 8,000 | 582,002 | 9,794 | 17.8 K to 9.8 K (-44.96 %) |
| May 08 2019 | ISIS | IONIS PHARMACEUTIC ... | MUTO FREDERICK T | Director | Buy | M | 24.42 | 8,000 | 195,360 | 17,794 | 9.8 K to 17.8 K (+81.68 %) |
| May 01 2019 | ISIS | IONIS PHARMACEUTIC ... | PARSHALL B LYNNE | Director | Option Exercise | M | 39.87 | 50,000 | 1,993,500 | 7,500 | |
| May 01 2019 | ISIS | IONIS PHARMACEUTIC ... | PARSHALL B LYNNE | Director | Sell | S | 75.01 | 50,000 | 3,750,635 | 52,677 | 102.7 K to 52.7 K (-48.70 %) |
| May 01 2019 | ISIS | IONIS PHARMACEUTIC ... | PARSHALL B LYNNE | Director | Buy | M | 39.87 | 50,000 | 1,993,500 | 102,677 | 52.7 K to 102.7 K (+94.92 %) |
| Apr 17 2019 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 39.87 | 700 | 27,909 | 2,500 | |
| Apr 17 2019 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 10.82 | 300 | 3,246 | 0 | |
| Apr 17 2019 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 39.87 | 13,320 | 531,068 | 57,180 | |
| Apr 17 2019 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 14.69 | 6,680 | 98,129 | 0 | |
| Apr 17 2019 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 10.82 | 1,000 | 10,820 | 300 | |
| Apr 17 2019 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 14.69 | 10,000 | 146,900 | 6,680 | |
| Apr 17 2019 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 84.75 | 700 | 59,325 | 5,532 | 6.2 K to 5.5 K (-11.23 %) |
| Apr 17 2019 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 39.87 | 700 | 27,909 | 6,232 | 5.5 K to 6.2 K (+12.65 %) |
| Apr 17 2019 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 84.75 | 300 | 25,425 | 5,532 | 5.8 K to 5.5 K (-5.14 %) |
| Apr 17 2019 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 10.82 | 300 | 3,246 | 5,832 | 5.5 K to 5.8 K (+5.42 %) |
| Apr 17 2019 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 84.56 | 13,320 | 1,126,370 | 69,634 | 83 K to 69.6 K (-16.06 %) |
| Apr 17 2019 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 39.87 | 13,320 | 531,068 | 82,954 | 69.6 K to 83 K (+19.13 %) |
| Apr 17 2019 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 84.75 | 6,680 | 566,130 | 69,634 | 76.3 K to 69.6 K (-8.75 %) |
| Apr 17 2019 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 14.69 | 6,680 | 98,129 | 76,314 | 69.6 K to 76.3 K (+9.59 %) |
| Apr 17 2019 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 85.25 | 1,000 | 85,250 | 5,532 | 6.5 K to 5.5 K (-15.31 %) |
| Apr 17 2019 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 10.82 | 1,000 | 10,820 | 6,532 | 5.5 K to 6.5 K (+18.08 %) |
| Apr 17 2019 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 85.25 | 10,000 | 852,500 | 69,634 | 79.6 K to 69.6 K (-12.56 %) |
| Apr 17 2019 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 14.69 | 10,000 | 146,900 | 79,634 | 69.6 K to 79.6 K (+14.36 %) |
| Apr 10 2019 | ISIS | IONIS PHARMACEUTIC ... | Geary Richard S | SVP, Development | Option Exercise | M | 39.87 | 20,000 | 797,400 | 25,000 | |
| Apr 10 2019 | ISIS | IONIS PHARMACEUTIC ... | Geary Richard S | SVP, Development | Option Exercise | M | 14.69 | 2,240 | 32,906 | 15,000 | |
| Apr 10 2019 | ISIS | IONIS PHARMACEUTIC ... | Geary Richard S | SVP, Development | Option Exercise | M | 47.34 | 24,000 | 1,136,160 | 1,439 | |
| Apr 10 2019 | ISIS | IONIS PHARMACEUTIC ... | Geary Richard S | SVP, Development | Sell | S | 84.00 | 20,000 | 1,680,000 | 21,442 | 41.4 K to 21.4 K (-48.26 %) |